Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers.
about
Targeting cellular metabolism to improve cancer therapeuticsLipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and HypoxiaMultidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic DrugsMechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase.Statins and pancreatic cancer.MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancerRepositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthaseUnbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisationMetabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS studyMolecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathwaysFatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide productionFASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.Metabolism addiction in pancreatic cancer.Biological determinants of radioresistance and their remediation in pancreatic cancer.Immunohistochemical expressions of fatty acid synthase and phosphorylated c-Met in thyroid carcinomas of follicular origin.Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism.Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells.Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer.Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer Cells.Inhibition of FASN expression enhances radiosensitivity in human non-small cell lung cancer.Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation.Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression.The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model.The Influence of Metabolism on Drug Response in Cancer
P2860
Q24596727-81482474-608F-4192-B883-8909E02AF7B2Q28078259-7367D23F-B4A4-4483-8EE8-162F2A577A01Q28547426-F7DE004D-6C3C-4F22-9623-766BE496F467Q30589786-6E67E55F-BBD3-465A-B8AB-9943CEFDE83FQ33597969-6DE753A0-1408-4E82-8077-D41BD52A2567Q33673940-9FD443FC-485D-4AA7-A6B1-FF03B0C39DD9Q33768197-F3B8F9F9-961E-4A19-B432-61C4DC023CA2Q35013508-7D26D8C9-95AA-4D32-98D2-CCAFCC631E5CQ35678372-89F90D4A-8A40-463E-8862-7A18D239A307Q35935362-A8520C20-F95A-49C4-8690-C5EB38817604Q36545995-3440B055-7CE2-4CC8-B7C1-06C5F94F639CQ36744130-32E0ECFF-0FB9-4C5F-9D2E-4846E9D4FA41Q37417939-32B351E6-6BBA-4CE9-959A-3A2DFB18E842Q37617965-C9F8FF84-C781-4F43-9AA0-828A22E463BFQ37620679-EFC65FFA-E10A-4988-9BDB-95649A41CE46Q39156722-AA3F9441-B021-4457-87F9-9016D42349DBQ39432024-2570FAF2-84F2-4230-9350-E4FF4D7B931CQ41084220-DF3355D9-C967-4CB6-BFAF-1D700A1BFEA3Q47754576-EBAC5A60-B4BF-4943-B5E0-DA73047425B4Q49685991-551BE052-4FCB-4BA0-8625-ED490BB3C15CQ50944315-11082436-93FF-45B6-9EAE-83AEA92B1603Q52655135-E612CC8B-D245-4E01-AC8F-C5F116A8F72EQ52681396-AF6B7816-EF3A-4C99-84A6-950CD19BC17EQ52716389-4F8D85A2-ED6E-4F72-A7D4-CD64DA78A8B5Q52724728-91999489-4AEE-4C0C-ADD8-3C0776D27706Q59136910-B8EC3BB5-2240-4B5D-939F-F03EA79B3264
P2860
Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@ast
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@en
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@nl
type
label
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@ast
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@en
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@nl
prefLabel
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@ast
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@en
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@nl
P2093
P2860
P1476
Role of fatty acid synthase in ...... istance of pancreatic cancers.
@en
P2093
C Max Schmidt
E Gabriela Chiorean
Hailan Liu
Jey-Hsin Chen
Jian-Ting Zhang
Jingwu Xie
Liang Cheng
Michelle Yip-Schneider
Qipeng Fan
Youyun Yang
P2860
P577
2011-01-01T00:00:00Z